A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia |
| |
| Authors: | Milena Kohn,Marc Delord,Maureen Chbat,Amina Guemriche,Fatiha Merabet,Anne-Laure Roupie,Naelle Lombion,Hassan Farhat,Thomas Longval,Auré lie Cabannes-Hamy,Juliette Lambert,Sté phanie Marque-Juillet,Victoria Raggueneau,Jennifer Osman,Marc Spentchian,Sophie Rigaudeau,Philippe Rousselot,Caroline Besson |
| |
| Affiliation: | 1.Service d’Hématologie Oncologie, Centre Hospitalier de Versailles, Le Chesnay;2.DRCI, Centre Hospitalier de Versailles, Le Chesnay;3.Service d’hématologie, Hôpital de Poissy, Poissy;4.Service de Biologie, Centre Hospitalier de Versailles, Le Chesnay;5.UVSQ, Inserm, CESP, Villejuif, France |
| |
| Abstract: | ![]()
|
| |
| Keywords: | |
|
|
